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Abstract
Background: Transcription is regulated by a complex interaction of activators and repressors. The
effectors of repression are large multimeric complexes which contain both the repressor proteins that
bind to transcription factors and a number of co-repressors that actually mediate transcriptional silencing
either by inhibiting the basal transcription machinery or by recruiting chromatin-modifying enzymes.
Results: TBLR1 [GenBank: NM024665] is a co-repressor of nuclear hormone transcription factors. A
single highly conserved gene encodes a small family of protein molecules. Different isoforms are produced
by differential exon utilization. Although the ORF of the predominant form contains only 1545 bp, the
human gene occupies ~200 kb of genomic DNA on chromosome 3q and contains 16 exons. The genomic
sequence overlaps with the putative DC42 [GenBank: NM030921] locus. The murine homologue is
structurally similar and is also located on Chromosome 3. TBLR1 is closely related (79% homology at the
mRNA level) to TBL1X and TBL1Y, which are located on Chromosomes X and Y. The expression of
TBLR1 overlaps but is distinct from that of TBL1. An alternatively spliced form of TBLR1 has been
demonstrated in human material and it too has an unique pattern of expression. TBLR1 and the
homologous genes interact with proteins that regulate the nuclear hormone receptor family of
transcription factors. In resting cells TBLR1 is primarily cytoplasmic but after perturbation the protein
translocates to the nucleus. TBLR1 co-precipitates with SMRT, a co-repressor of nuclear hormone
receptors, and co-precipitates in complexes immunoprecipitated by antiserum to HDAC3. Cells
engineered to over express either TBLR1 or N- and C-terminal deletion variants, have elevated levels of
endogenous N-CoR. Co-transfection of TBLR1 and SMRT results in increased expression of SMRT. This
co-repressor undergoes ubiquitin-mediated degradation and we suggest that the stabilization of the co-
repressors by TBLR1 occurs because of a novel mechanism that protects them from degradation.
Transient over expression of TBLR1 produces growth arrest.
Conclusion: TBLR1 is a multifunctional co-repressor of transcription. The structure of this family of
molecules is highly conserved and closely related co-repressors have been found in all eukaryotic
organisms. Regulation of co-repressor expression and the consequent alterations in transcriptional
silencing play an important role in the regulation of differentiation.
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Background
TBLR1 is a transcriptional regulator interacting with the
co-repressors of nuclear hormone receptor activity. We
cloned the gene encoding this protein and identified it as
a member of a small family of proteins that include at
least two isoforms encoded by the same gene and closely
related, X- and Y linked proteins, called TBL1X and TBL1Y.
The TBLR1 protein interacts with NHR (nuclear hormone
receptors), a class of molecules that plays a critical role in
transcription [1]. These co-repressors mediate the down-
regulation of gene expression and play important roles in
the life and death choices that regulate normal develop-
ment.
The nuclear hormone receptor (NHR) superfamily is a
large family of mainly ligand-dependent transcription fac-
tors that play a role in the regulation of reproduction,
growth, differentiation, and homeostasis. Members of the
family share several structural features including a con-
served DNA binding domain (DBD) that targets the recep-
tor to hormone response element (HRE) sequences. The
carboxyl-end of the receptors contains a ligand-binding
domain (LBD) in which is embedded a hormone-depend-
ent transcriptional activation domain. The LBD serves as a
molecular switch that recruits co-activator or co-repressor
proteins that regulate transcription of the target genes. Lig-
and-dependent receptors like the thyroid hormone recep-
tor (T3R) and retinoic acid receptor (RAR) stimulate
transcription when ligand is bound and repress it when
the ligand is absent [2].
N-CoR (nuclear receptor co-repressor)[3] and SMRT
(silencing mediator of retinoid and thyroid hormone
receptors [4] were the first identified co-repressors. They
fill overlapping but non-redundant roles in regulating
transcription. Both SMRT and N-CoR exist in multi- pro-
tein complexes that have an estimated size of 1.5–2 mDa.
A SMRT complex, isolated by a combination of conven-
tional and immunoaffinity chromatography has been
shown to contain histone deacetylase 3 (HDAC3) and
transducin (beta)-like I (TBL1). The HDAC3-containing,
SMRT and N-CoR complexes can bind to unliganded thy-
roid hormone receptors (T3Rs) in vitro[5]. Although both
co-repressors are expressed widely, extensive hematologi-
cal abnormalities, including blocks in erythrocyte and T-
cell development [6], follow targeted deletion of N-CoR.
Co-repressors mediate transcriptional silencing by inhib-
iting the basal transcription machinery and by recruiting
chromatin-modifying enzymes [2,5,7-11] Histone
deacetylation, which produces a more compact chromatin
structure that is inaccessible to transcriptional activators
[8], appears to be the predominant means of chromatin
modification. Studies of RAR and T3R show that ligand
binding leads to the displacement of an HDAC-contain-
ing complex from the nuclear receptor in exchange for a
histone acetyltransferase (HAT)-containing complex and
this may serve as a general mechanism for switching
nuclear receptors from a transcriptionally repressive to a
transcriptionally active state [12]. Changes in repression
correlate with alterations in the level of N-CoR and/or
SMRT. These levels are regulated by both the rate of syn-
thesis of the co-repressors and, more dramatically, by
their rate of degradation. Targeted proteolysis of transcrip-
tional co-regulators has been established as a mechanism
for cell-specific regulation of gene transcription [13].
Although the composition of the repressor complex is not
fully understood, both TBLR1 and a protein called TBL1
that is highly homologous to TBLR1, are present and in
some cells, the extent of transcriptional repression corre-
lates with the amount of TBL1 present [9,14,15].
We originally isolated TBLR1 as a 201 bp fragment in a
cDNA library prepared from a bone marrow preparation
highly enriched for human hematopoietic stem cells [16].
This fragment, which had no homology with any
sequence in the GenBank, hybridized with RNA from
K562 (a human erythroleukemia cell line) and a placental
library and cDNAs prepared from these tissues were used
as a source of mRNAs for subsequent analysis. 5' RACE
identified an open reading frame (ORF) encoding a puta-
tive 514 a.a. protein. In this paper, we report the structure
of the TBLR1 gene and analyze its pattern of expression.
These results indicate that alternative splicing of the
mRNA results in the formation of at least two protein iso-
forms (termed α and β). Over expression of TBLR1 inter-
feres with cell replication. Like TBL1, TBLR1 forms a
complex with nuclear co-repressors and appears to play a
role in stabilizing the active co-repressor complex.
Results
The TBLR1 family
Human TBLR1 exists as two isoforms that differ at their
carboxyl end. The original isolate (now termed TBLR1α
[GenBank: NM024665] was characterized using 5' exten-
sion of an mRNA fragment identified by differential
amplification of subtracted cDNAs [16]. This sequence
contained a complete open reading frame (ORF) and in
vitro translation of an RNA prepared from the full-length
cDNA, yielded a product of the predicted size (data not
shown). Because the size of the assembled sequence (3.9
kB) was significantly smaller than the 7.6 kB message
identified by Northern blotting (see below), a series of
primers were constructed for use in 3' RACE in an attempt
to identify RNA sequences that extended beyond the poly
A site that characterized the 3' end of the original mole-
cule. While none of these attempts was successful, primers
selected from the middle of the ORF (bridging exons 13
and 14) revealed the existence of two messages that were
identical at their 5' ends but differed at their 3' ends. TheBMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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second of these mRNAs is termed TBLR1β [GenBank:
AF268194]. Examination of the genomic sequence encod-
ing TBLR1 revealed that these were produced by the fail-
ure of recognition of the splice donor site that normally
demarcates the end of exon 14. In the variant, the follow-
ing intron is not removed from the transcribed mRNA. It
is translated to produce the alternative beta form. Thus the
two isoforms are identical through exon 14 but the 15th
exon of the beta variant is encoded by a sequence that
begins immediately after exon 14 without an intervening
splice. while the exon 15 of the alpha form is encoded by
a sequence located 6000 bp down stream. The deduced
amino acid sequences of the divergent carboxyl-ends are
included in the Materials and Methods section.
The nucleic acid sequence encoding TBLR1α is highly con-
served. At the nucleic acid level the similarity in the open
reading frame between the human and mouse genes is
89% but interestingly, in the 3' UTR, the first 500 bp have
the same degree of similarity (88%) as the open reading
frame. The next several 100 bp contain several smaller
regions (40 – 70 bp) of almost complete identity. The
sequence of the human mRNA recorded in GenBank
[GenBank: NM024665] is 3950 bp; the homologous
murine sequence [GenBank: AF268195] containing the
open reading frame is 1800 bp but the 3' end of this
sequence shares a 400 bp overlap with the 5' end of a
1750 bp cDNA sequence [GenBank: BCO18512], suggest-
ing that the full-length message is actually at least 3150
bp. The human [GenBank: NP078941] and mouse pro-
teins are remarkably similar (98% identity).
TBLR1 has a high degree of similarity (90% identity or
conservative substitution) to a pair of proteins encoded
on the X and Y chromosomes (TBLX1 [GenBank:
NP005638] and TBLY1 [GenBank: NP150600]. The
mouse TBL1 protein [GenBank: XP135950] is equally well
conserved (92% similar). These proteins are also highly
homologous to a drosophila protein known as Ebi [Gen-
Bank: EA.A.12470; 85% similar] as well as to Anopheles
gambiae [GenBank: EA.A.12470; 82% similar] and Arabi-
dopsis thaliana [GenBank: NP201533; 73% similar] pro-
teins. The yeast protein SIF2p, a SIR4 interacting factor
[GenBank: NP009661] is 43% similar, indicating wide
evolutionary conservation. Highly homologous proteins
have also been found in chimpanzees, dogs, cows fish and
chickens. The relationships among the proteins are illus-
trated in Figure 1.
The TBLR1 protein contains a series of WD40 repeats that
are permuted with respect to the structural repeats
(blades) of the β propeller domain. The amino-terminal
end contains a perfect copy of the Lissencephaly type-1-
like homology motif (LisH), an α-helical motif present in
numerous WD40 repeat-containing proteins.
Genomic structure of hTBLR1
TBLR1 is located on chromosome 3 at 3q26. The gene
occupies ~200,000 bp and the coding structure is assem-
bled from 18 exons. Neither the first nor the last of these
are included in the current Genebank assembly but are
included here as result of Northern blotting evidence. The
translational start site is located in the 5th exon and is
~150 kb downstream from the first exon. The actual 3' end
of the gene extends at least 2.2 kB beyond the sequence
that we originally reported [16]. A probe synthesized to
detect the hypothetical protein DC42 [GenBank:
NM030921] which is located 3' of the previously charac-
terized end of TBLR1, hybridizes with the mRNA encod-
ing TBLR1 (see below). The sequence reported for DC42
encodes a putative small (102 a.a.) intronless protein that
has no significant similarity to any other protein in Gen-
Bank from any organism. The mouse sequence is assem-
bled from 16 exons and is located on chromosome 3
(between 3A2 and 3A3). The structure of the human gene
is shown in Figure 2.
Expression of TBLR1
The expression of the messages for TBLR1, as well as that
for TBL1X were examined using quantitative real time
PCR. The results are shown in Figure 3a. Expression varies
widely from tissue to tissue. In many tissues, including
thymus, spleen, thyroid, lung and brain TBLR1 expression
exceeded TBL1. On the other hand, in ovary, prostate and
placenta, which have the highest overall levels of these
mRNAs TBL1 greatly exceeded TBLR1. Little correlation
was found between TBLR1 expression and TBL1 expres-
sion (Figure 3b) but expression of TBLR1β, the splice var-
iant, generally correlated with the expression of the
predominant alpha form (Figure 3c). The proportion of
the splice variant varied from tissue to tissue but in no case
was it the predominant form. Northern analyses with
probes from different regions of the TBLR1 message (Fig-
ure 3d) produced complex results. A probe from the 3'
untranslated region detects a 7.6 kb transcript in many tis-
sues. Hybridization with a probe containing the 5' end of
the ORF identified 3 mRNAs. In addition to the 7.6 kb
band there is an abundant 3.9 kb message and a variably
expressed band of ~4.9 kb that is most often detected in
hematopoietic tissues. Mouse tissues show a similar pat-
tern. An oligonucleotide probe specific for the 3' end of
TBLR1β detected only the 4.9 kb mRNA. Hybridization
with a probe designed to detect the theoretical protein
DC42, which maps 2.2 kb downstream from the pre-
sumed 3' terminus of the message, hybridizes with a 7.6
kb message that appears to be identical to the one
detected by probes that hybridize with the ORF. Hybridi-
zation with a probe designed to detect the cDNA sequence
[GenBank: AK02 2268] also detects the 7.6 kb transcript
of TBLR1. This sequence was identified in a human mam-
mary cDNA library and maps in the large first intronBMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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deduced from the genomic sequence. It is not present in
either our original isolate or any of the subsequently iso-
lated clones. Its presence in the predominant transcript
detected by Northern analysis of TBLR1 indicates the pres-
ence of additional splice variants of this gene. Hybridiza-
tion with this probe also detects an ~3.7 kb RNA whose
origin is unknown. No sequences that are homologous to
[GenBank: AK022268] have been detected on the X or Y
chromosomes where TBL1 is located.
Western blots were prepared using three polyclonal anti
TBLR1 peptide antibodies; antibodies directed against the
carboxyl end of TBLR1α and TBLR1β and an antiserum
specific for the region of maximal difference between
TBLR1 and TBL1. This later antiserum does not react with
TBL1 at all and enabled us to distinguish between TBLR1
and TBL1 in mouse tissues. TBLR1 was first isolated by
immunoaffinity chromatography using the antiserum
that distinguishes between TBLR1 and TBL1 and the
Comparison of the amino acid sequence of TBLR1 with other family members and with the homologous proteins in other spe- cies Figure 1
Comparison of the amino acid sequence of TBLR1 with other family members and with the homologous pro-
teins in other species. The proteins shown in this alignment are: TBLR1-human.............................. NP078941, TBLR1-
mouse............................... NP109657, TBL1X-human.............................. NP005638, TBL1Y-human............................... NP150600, 
TBL1-mouse.................................. XP135950, Ebi CG4063-PA [D. melanogaster] NP477329, A. gambia str. PEST....................... 
EA.A.12470, Arabidopsis; protein id: At5g........ NP201533, SIR4-interacting factor; SIF2p...... NP009661, Only proteins with 
homology to both the LisH domain (near the amino terminus) and the WD40 domains are included in the comparison. Regions 
of amino acid identity are shown in black; conservative substitutions are shown in gray. The large regions of non-homology are 
the result of insertions in the Arabidopsis and yeast sequences that have no counterparts in the other species.BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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eluted material was electrophoresed and then blotted
with anti TBLR1α and anti TBLR1β antisera. The pattern
produced by anti TBLR1α using mouse tissues is shown in
Figure 4a. The anti TBLR1β antiserum is unfortunately not
useful for western blotting. Despite our inability to detect
the mouse beta form by western blotting, complex pat-
terns that varied from tissue to tissue were observed when
the antibody that detects both isoforms was used. A com-
ponent with the molecular mass (~56 kD) predicted by
the sequence of the ORF (Figure 4a) is present in most tis-
sues but in some tissues, an additional component at ~60
kDa was also detected. The larger component was found
in both mouse and human hematopoietic tissues (data
not shown) and is prominent in extracts of mouse testes.
The addition of soluble peptide to the diluted antiserum
inhibited all of the staining (data not shown). In mouse
bone marrow the predominant form is also a 56 kDa pep-
tide. The highest levels of TBLR1 are present in fetal liver
and immunohistochemical staining shows strong staining
of hematopoietic cells in the developing liver (Figure 4c).
The immunohistochemical results indicate that the pre-
dominant isotype in the fetal liver is the beta form.
The human kidney cell line 293T expresses readily detect-
able quantities of TBLR1 (Figure 4b). Anti TBLR1α pro-
duces a single band at ~56 kDa, while anti TBLR1β detects
only a larger band at ~60 kDa. The results obtained with
the antibody that distinguishes between TBLR1 and TBL1
are also shown in Figure 4b. This antibody, made with a
peptide unique to TBLR1, is directed at an epitope shared
by both the α and β isoforms and detects both bands. The
results are particularly informative since they demon-
strate; 1) more than one form of TBLR1 exists. 2) the β-iso-
form identified by 5'RACE and quantified by quantitative
real time PCR, encodes an expressed protein; 3) a single
cell type produces more than one isoform; and 4) the
higher molecular weight form detected by the antibody to
the C-terminal fragment of the β form is likely to be
TBLR1 and not TBL1. Although the peptide used for the
immunization of the animals that made the affinity
absorbed antibody is not present in TBL1, the possibility
that TBL1 forms a heterodimer with TBLR1 and is thus co-
precipitated by anti TBLR1 has not been completely elim-
inated.
Map of exons from TBLR1α and TBLR1β transcripts on the human chromosome 3q23 genomic sequence Figure 2
Map of exons from TBLR1α and TBLR1β transcripts on the human chromosome 3q23 genomic sequence. The 
sequences in the exon marked with asterisks were not included in the original description of TBLR1 and are not included in 
NM024665.2. The first sequence [GenBank: AK022268] (*) maps on chromosome 3 between the first 2 exons of TBLR1. The 
second sequence [**] is DC42 [AF267864] and maps immediately 3' to TBLR1. The actual 3'end of the gene has not been 
experimentally defined. mRNA numbering begins with the first nucleotide identified at the 5' end of the sequence and the 
genomic sequence is numbered from the corresponding base in the DNA. The sequence begins with bp 12127476 of [Gen-
Bank: NT_005962.15].BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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Expression of TBLR1 Figure 3
Expression of TBLR1. a. Quantitative real time RT-PCR analysis of the expression of TBLR1, TBLR1β and 
TBL1 m RNA. The data shown are relative concentrations of mRNA normalized to the concentration of GAPDH mRNA 
found in each tissue. b. Correlation of TBLR1 & TBL1 Expression. The data shown were extracted from Figure 3a and 
compare the level of expression of TBLR1 and TBL1. c. Correlation of TBLR1 &TBLR1β Expression. The data shown 
were extracted from Figure 3a and compare the level of expression of total TBL1 and TBLR1β. d. Northern analysis. Blots 
of human total RNA (Multiple Tissue Northern Blot™) or blots prepared using RNA extracted from several human hemat-
opoietic cell lines were analyzed with 32P labeled probes as shown in the figure. The same filter was used for all the tissue 
hybridizations. Between hybridizations the bound radioactive probes were stripped and the filter exposed to fresh film to 
assure that the stripping had been complete. The autoradiographs were scanned to produce the images shown.
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a. Expression of TBLR1 in mouse tissues (Western Blotting) Figure 4
a. Expression of TBLR1 in mouse tissues (Western Blotting). Anti peptide antibodies were made against deduced 
sequences from TBLR1. The antibody used was prepared against a sequence unique to TBL1 does not react with TBL1. After 
transfer, the membranes were stained with polyclonal rabbit anti-TBLR1 peptide antibodies and the transferred proteins visu-
alized with HRP-labeled donkey anti-rabbit IgG. The bound HRP was detected using luminol as the substrate. b. Expression 
of TBLR1 by HK293T cells (Western Blotting). TBLR1 proteins were isolated by immuno-affinity chromatography from 
lysates of HK293T cells. Rabbit anti-TBLR1(117-125), covalently coupled to the gel, was used as the immunoadsorbant. The 
bound material was eluted with a glycine-HCl buffer (pH 2.8) and then run on the gels. After transfer to nitrocellulose, these 
were stained with either anti TLR1α or TRLR1β or with anti anti-TBLR1(117-125) which detects both isoforms. The proteins 
were visualized as above. c. Immunohistochemical Detection of the expression of TBLR1 in human fetal liver. All 
of the samples were from 17 week fetuses. The sample on the left was stained with the anti-TBLR1 antiserum that detects both 
isoforms but does not detect TBL1. The staining was detected with HRP coupled goat anti rabbit IgG using DAB as the chrom-
agen. The original magnification was 40×. A digital image was captured and cropped in Photoshop. The images on the right 
show samples stained with the specific anti α and β sera. They were also detected with HRP coupled goat anti rabbit IgG but 
using AEC as a chromagen. The images were captured on film and then scanned to produce the digital images shown. The orig-
inal magnification was 40×. The hematopoietic cells of the fetal liver stained more intensely with the anti TBLR1β antiserum. All 
of the samples were counterstained with haematoxylin.
a.  Western blot ( mouse tissues)                       b.  Western blot  (293T cells)  
   c.  Imunohistochemical demonstration of TBLR1 expression in human fetal liver. 
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Intracellular localization of TBLR1
To determine the intracellular localization of TBLR1, the
anti-peptide antibodies described above were used in an
indirect immunofluorescence assay. The target cells were
mouse 3T3 fibroblasts. The results are shown in Figure 5.
In 3T3 growing under normal conditions, the staining is
primarily cytoplasmic (Figure 5a and 5d). In serum-
starved cells, the staining increased dramatically and
nuclear (Figure 5b and 5e) and nuclear staining became
prominent. After treatment with camptothecin (CPT; Fig-
ure 5d and 5f), the intensity of both cytoplasmic (with
perinuclear intensification) and nuclear staining
increased. Staining for total TBLR1 (panel a, b, and c) or
just TBLR1β gave qualitatively similar results but anti
TBLR1β staining was almost totally nuclear after serum
starvation but remained predominantly cytoplasmic after
CPT. The increase in nuclear staining suggests that under
conditions of stress TBLR1 levels increase, and suggests a
physiologic role for TBLR1 in the response to these stim-
uli.
Interaction of TBLR1 with SMRT
The interaction of TBLR1 with components of the tran-
scription regulatory complex can be demonstrated by
both GST "pull-down" and co-precipitation. Labeled
TBLR1 prepared by in vitro translation using 35S methio-
nine can be "pulled-down" by an immobilized amino ter-
minal fragment of SMRT. As shown in Figure 6A, full-
length TBLR1 is pulled down by GST SMRT(1-300) but
does not bind to a control GST column. Truncated forms
of TBLR1 lacking the F-Box (TBLR1 [δ 43-88]), the N-ter-
minal 44aa (TBLR1 [89-515] or even just lacking the
amino terminal 9aa (TBLR1 [10-515] are not pulled down
by the truncated SMRT (Figure 6B.) indicating that both
the putative F-box and the N-terminus are critical for a
high affinity interaction of TBLR1 with SMRT. A fragment
consisting only of the first 230 a.a.(TBLR1 [1-89] = TBLR1
[δC] i.e. lacking all of the WD40 repeats and the carboxyl
terminus) was as efficient as the full-length protein in
reacting with SMRT.
Sequences required for the interaction of TBLR1 with SMRT Figure 6
Sequences required for the interaction of TBLR1 
with SMRT. a. TBLR1 constructs were cloned in-frame into 
pCDNA3 with an N-terminal Flag tag. b. HuSMRT cDNA (1-
900) was PCR-amplified and cloned in-frame into PGEX-6p-
1. EcoR1 linearized plasmids were purified and used as a tem-
plate for in vitro translation using 35S methionine. Expression 
of the GST fusion protein was induced with IPTG and the 
product adsorbed onto Glutathione sepharose 4B. For the 
pull-down experiment, 5 ng of 35S labeled and 20 ul of GST 
agarose were mixed. After incubation the bound material 
was eluted and electrophoresed through a 10% SDS PAGE 
gel. 10% of the labeled material was reserved and electro-
phoresed separately to demonstrate the efficiency of the 
original labeling.
Intracellular localization of TBLR1 Figure 5
Intracellular localization of TBLR1. 3T3 cells respond 
to apoptotic stimuli with increased expression of TBLR1 and 
with translocation of TBLR1 into the nucleus. grown in on 
collagen coated cover slips were used. Untreated cells in the 
log phase of growth are shown in panels a and d. Apoptosis 
was induced by either serum starvation (incubation with 
DMEM containing 0.2% FBS for 16 h) [panels b and e] or 
growth with100 ng/ml of the topoisomerase inhibitor, camp-
tothecin (CPT) [panels d and f]. The top panels [a, b, and c] 
were stained for total TBLR1 with anti TBLR1 [117-125] 
while the bottom panels [d, e, and f] were stained with anti 
TBLR1β. The images were obtained using a Leitz Orthlux 
microscope at an original magnification of 600 × with a 
Nikon 60X phase fluorescence objective (NA 1.4) and cap-
tured with a Nikon digital camera.BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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We have also confirmed that TBLR1 associates with
HDAC3. In cells transfected with either his-tagged
HDAC3 alone or his-tagged HDAC3 along with a flag-
tagged TBLR1, the flag-tagged TBLR1 binds only to Ni-aga-
rose columns that have bound HDAC (Data not shown).
Effect of co-transfection of TBLR1 on SMRT and NCoR 
expression
Expression of the SMRT truncate is greatly increased in
cells expressing both SMRT(1-300) and TBLR1. Truncated
forms of TBLR1 (TBLR1 [δC] and TBLR1 [δ N+F-box]
increase the level of SMRT(1-300) more than the wild type
molecule (Figure 7a). The effect is seen with the fragment
that binds SMRT (TBLR1 [δC]) and one that lacks the N-
terminal binding site for N-Cor or SMRT (TBLR1 [δ N+F-
box]). The expression of the TBLR1 mutants varied con-
siderably after transfection. The greatest increase in
SMRT(1-300) expression (8 fold) was produced by co-
transfection with TBLR1 [δN], which was also the most
highly expressed TBLR1 protein. However the next most
effective protein was TBLR1 [δC] (4 fold increase in
SMRT), which was the least expressed of the three TBLR1
proteins. Co-transfection with full-length TBLR1 resulted
in an ~3 fold increase in SMRT(1-300). Co-transfection
with siah-1, a factor known to contribute to the targeting
of N-CoR for proteolytic destruction did not affect
SMRT(1-300) expression. These results were obtained
analyzing the transient expression of a SMRT fragment.
To confirm their physiologic relevance of these results, the
experiment was repeated with cells engineered to stably
express the TBLR1 constructs as a consequence of retrovi-
ral infection. The expression of endogenous N-CoR in
these lines was examined using western blotting (Figure
6b). The results were similar to those found after co-
expression of the TBLR1 truncates and the SMRT frag-
ment. All of the lines that ectopically expressed TBLR1 or
its truncates showed increased steady state expression of
N-CoR To assure that the increase in protein expression
was not a consequence increased mRNA expression, the
expression of N-CoR message was assessed by quantitative
real-time RT-PCR (Figure 7b). GAPDH was used as a con-
trol. The levels of N-Cor mRNA in cell lines that expressed
TBLR1, TBLR1 [δC] or TBLR1 [δN] were indistinguishable
from the control line.
Effect of proteasome inhibitors on SMRT(1-300) 
expression
To demonstrate that the levels of SMRT(1-300) found in
COS 7 cells are controlled by ubiquitination we treated
the transfected cells with MG132 in DMSO or with DMSO
as a control and measured the level of SMRT by Western
blotting as described above. MG 132 (N-CBZ-Leu-Leu-
Leu-al) is a potent, membrane-permeable proteasome
inhibitor[17]. To control for differences in cell survival
etc., the COS cells were co-transfected with a vector that
expressed GFP along with the His-SMRT vector. GFP is not
degraded via the ubiquitin-proteasome pathway. As
shown in Figure 8, MG132 treated COS7 cells express lev-
els of SMRT that are ~25 times those found in the DMSO
control. Only a relatively small difference in GFP expres-
sion was observed.
Effect of ectopic expression of TBLR1 on cell growth
Transient expression of TBLR1or the truncated form lack-
ing the WD40 domains in HK293 T cells leads to growth
arrest. After transfection almost half of the cells that
expressed full-length TBLR1 or the truncated form lacking
the C-terminal half of the molecule (TBLR1 [δC]) fail to
undergo a single round of mitosis within 3 days. This non-
proliferative fraction, which was 0.24 after the control
transfection, increased to 0.48 (TBLR1); 0.46 (TBLR1
[δC]) and 0.36 (TBLR1 [δN]) after transfection with
TBLR1 constructs. The proportion of cells that divided 3
times (4th generation) was reduced from 25% after trans-
fection with the control vector to between 9 and 11% after
transfection with TBLR1 or its truncates. The interference
with growth was apparent even among cells that escaped
the initial block. The proliferative index (a measure of the
growth of the cells that escaped the initial growth arrest)
decreased from 2.18 after transfection with the empty vec-
tor to 1.54 (TBLR1); 1.56 (TBLR1 [δC]) and 1.75 (TBLR1
[δN]). The results are illustrated in Figure 9a and summa-
rized in Table 1. Transfection with TBLR1 [δN] produced
a more modest block than transfection with either the fill-
length material or TBLR1 [δC].
Stable ectopic expression of TBLR1 also alters the growth
properties of Jurkat cells. The growth rate of cells infected
with retroviruses containing the same constructs used in
the transient experiments is shown in Figure 9b. In 5 inde-
pendent experiments, cells over expressing full-length
TBLR1 or the truncated form lacking the C-terminal half
of the molecule (TBLR1 [δC]) show a significant reduction
in growth rate. Cells expressing TBLR1 [δN] grew at a rate
that was statistically indistinguishable from cells infected
with a virus containing only GFP. To determine the basis
for the reduced growth rate, cells in the log phase of
growth, were stained with propidium iodide to determine
their DNA content. The results (Figure 9c) show a consist-
ent reduction in the proportion of cells in the G2/M phase
of the cell cycle in cells expressing either full length TBLR1
or TBLR1 [δC]. This decrease in G2/M cells is associated
with increases in the proportion of cells in both the G0/
G1 and S phases of the cycle, suggesting that over-expres-
sion of TBLR1 can contribute to both G0/G1 and S phase
arrest. This results is consistent with the known effects of
HDAC (to which TBLR1 binds) and chromatin remode-
ling complexes (which contain TBLR1) in regulating cell
division. [18-21].BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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Discussions and conclusion
TBLR1 gene is expressed widely and Northern analysis,
using sequences from the ORF as a probe, revealed size
heterogeneity of the expressed mRNAs (3.9, 4.7 kb and
~7.3 kb). These are due to both the presence of alterna-
tively spliced messages and the presence of multiple poly-
adenylation sites. The 4.7 kb form is more abundant in
hematopoietic tissues. In addition to the heterogeneity in
message size, the protein also has several isoforms. The
isoforms are produced by the use of alternative splice
donor sites. TBLR1β, differs from the original sequence at
the carboxyl-terminus (3' end of the ORF). The mouse
Expression of TBLR1 alters the expression of SMRT and N-CoR Figure 7
Expression of TBLR1 alters the expression of SMRT and N-CoR. a. Transient expression of TBLR1 alters the 
expression of co-transfected SMRT(1-300). COS7 cells were co-transfected with pCDNA His-SMRT(1-300) and the His-
tagged TBLR1 constructs described above. Control cells were transfected with pCDNA His-SMRT(1-300) and an empty vec-
tor.36 hrs after transfection the cells were lysed and equal amount of proteins were electrophoresed in SDS-PAGE gel. After 
transfer anti-His mAb was used to detect the transiently expressed proteins. The TBLR1 constructs used in this experiment 
were also His-tagged and are visible on the blot after staining. They are marked with * in the figure. The immuno-precipitates 
were quantified by phosphorimaging. After stripping, the blots were restained with anti ERK as a control for loading differ-
ences. b. Stable expression of TBLR1 alters the expression of endogenous N-CoR. Jurkat were infected with retrovi-
ruses expressing TBLR1 or the TBLR1 [δN] and TBLR1 [δC] construct. The retroviral vector also expressed GFP which was 
used to identify the infected cells. After two rounds of sorting the cells were analyzed by Western blotting for their expression 
of N-CoR. Th blot was then stripped and restained with an antibody to α tubulin as a loading control. c. Stable expression 
of TBLR1 does not alter the expression of endogenous N-CoR or SMRT message. mRNA was prepared from the 
cell lines used in Figure 3b and examined using quantitative real-time RT-PCR. Primer pairs that identified GAPDH and N-CoR 
were used. The results shown are representative of 3 experiments performed in triplicate. The samples are labeled as follows: 
black = control Jurkat; red = Jurkat (TBLR1); blue = Jurkat (TBLR1 [δC]); green = Jurkat(TBLR1 [δN])
                                                                      b. 
   a.                                                                      
                                                        
        c.                                                     
Expression of Endogenous N-Cor
mRNA Expression
N-CoR
α α α α tubulinBMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
Page 11 of 17
(page number not for citation purposes)
homologue shows mRNA size heterogeneity that is simi-
lar to the human RNA. Both the human and mouse genes
have a complex and somewhat unusual genomic struc-
ture. The human gene contains 18 highly conserved exons
spread over 230 kb of genomic DNA. The first and second
exons are ~140 kb upstream of the third, which in turn, is
separated from the fourth exon by 33 kb of intronic DNA.
The translational start site is located an additional 11 kb
downstream in the middle of the fifth exon. The gene also
has an extremely long 3'UTR that includes a sequence
deposited in GenBank as DC42. This is described as an
intronless gene for which there is no independent evi-
dence of expression and may not actually encode a func-
tional message. Human TBLR1 maps to chromosome
3q26 while mouse TBLR1 is located between 3A2 and
3A3.
The broad evolutionary conservation of this gene family is
of note. Homologs are present in yeast, plants, fish and
flies as well as in mammals and the insect proteins are >
80% similar to the mammalian ones. No homology was
detected to prokaryotic genomes.
The cDNAs for TBLR1 encode members of the β-trans-
ducin or WD-repeat family [22]. Eight WD-repeats are
present in both the human and mouse proteins. The splice
site that distinguishes between TBLR1α and TBLR1β is
immediately 3' of the last WD-repeat sequence signature.
At the nucleotide level, the sequence of TBLR1α has 79%
homology to Homo sapiens mRNA for transducin (β)-1
like protein (TBL1) [GenBank: Y12781]. The only homol-
ogy of TBLR1 and TBL1 to the prototypic signal transduc-
ing guanine nucleotide binding regulatory (G) protein β
sub- unit is in the WD-repeat domains. TBL1 has been
mapped to the X chromosome and deletions in the region
containing TBL1 are associated with adult onset sen-
sorineural deafness[23]. Both TBLR1 and TBL1 are
homologous to a Drosophila protein called ebi  The
regions of maximal nucleotide conservation between
TBL1 and ebi are at the N-terminal end of the molecule
and in the WD40 repeats. The C-terminal ends of these
proteins are not homologous. The carboxyl terminal exon
of TBLR1α has some homology to several members of the
Arp2/3 complex of proteins that control actin polymeriza-
tion [24]. The equivalent region of TBLR1β has no homol-
ogy to any known protein. The N-terminal 100 amino
acids of TBLR1 co-precipitates with both HDAC3 and
SMRT. The data indicate that TBLR1 binds directly to
SMRT, which in turn binds HDAC3. SMRT binding of
HDAC3 plays an important role in regulating chromatin
structure and gene expression[5,25,26] The homologous
region of TBL1 also co-precipitates with these co-repres-
sors [9,10] and has been reported to form an effective
transcriptional repressor. This portion of the molecule
contains a LisH motif. LisH is a β-propeller-binding motif
Effect of proteasome inhibitors on SMRT (1-300) expression Figure 8
Effect of proteasome inhibitors on SMRT (1-300) 
expression. COS7 cells, expressing His -SMRT(1-300) and 
GFP-His6 were treated with 15 um MG132 for 10 hours. The 
His-tagged proteins were detected by Western blotting.
Table 1: Proliferation HK293T after transfection with TBLR1
Empty Vector TBLR1 Delta C Delta N
Parent 23.80% 48.40% 45.30% 36.20%
Generation 2 25.50% 20.40% 25.40% 25.40%
Generation 3 24.40% 21.10% 17.70% 27.00%
Generation 4 25.20% 8.90% 9.60% 10.80%
Generation 5 0.70% 1.10% 1.50% 0.50%
Generation 6 0.40% 0.00% 0.20% 0.00%
Proliferation Index 2.18 1.54 1.56 1.75
Fraction of non-dividing cells 0.24 0.48 0.46 0.36BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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Growth inhibition after transfection with TBLR1 Figure 9
Growth inhibition after transfection with TBLR1. a. DiI staining of HK293T cells 72 hours after transfection 
with TBLR1 constructs. The cells were stained with DiI prior to transfection. The lipophilic dye distributes to both daugh-
ter cells after division and the loss of the dye reflects the number of times the cells have divided. The color filled curves are the 
computer generated model of the components of the mixed population. b. Growth of JURKAT cells over-expressing 
TBLR1. JURKAT cells infected with retroviral constructs expressing only GFP or GFP and a TBLR1 construct were seeded at 
a concentration of 25,000 per ml in 12 well Costar plates. Each day the entire contents of a well was removed and counted 
using a Coulter Model Zf cell counter. Each culture was performed in triplicate and the mean and S.D have been plotted. c. 
Cell cycle parameters (DNA content) of log phase JURKAT cells ectopically expressing TBLR1. Cells were har-
vested while in log phase of growth (72 hrs after plating at 50,000 cell per ml) and stained with PI as described. Fluorescence 
from PI bound to DNA was analyzed using a BD FACScan cytometer and the list mode data analyzed using ModFit (Verity Soft-
ware) to calculate cell cycle parameters.
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and is thought to mediate the dimerization of WD-40 pro-
teins [27-29] Sif2p, the yeast homolog of TBLR1, is a
tetramer and contains an unusual eight-bladed β-propel-
ler structure, that apparently mediates tetramerization
[30]. Mutations in conserved LisH amino acids signifi-
cantly reduced the half-life of TBL1 and altered its intrac-
ellular localization. TBL1 mutated in the LisH domain
was not imported into the nucleus [31]. Our data indi-
cates that elimination of the LisH domain prevents inter-
action with SMRT.
The actual role that the TBLR1 family plays in cell physi-
ology remains unclear. Like the proverbial blind man try-
ing to describe an elephant, each laboratory has found a
role for family members in their own system. Presumably,
TBL1 and TBLR1 are multi-functional proteins. We found
TBLR1 in a screen for messages over-expressed in early
hematopoietic cells [16]. TBL1 deletions are associated
with deafness [23]. The drosophila homolog, ebi has been
reported to regulate epidermal growth factor receptor sig-
naling [32] promote the degradation of a repressor of neu-
ronal differentiation (Ttk88), and to limit S phase entry. A
cDNA, described as the "human homologue of ebi" was
reported to encode a protein that plays a role in the ubiq-
uitin pathway [33]. More recently, both TBL1 and TBLR1
were reported to be required for transcriptional activators
of nuclear hormone receptors and other regulated tran-
scription factors [34]. Cofactor exchange through ubiqui-
tin-dependent protein degradation was proposed to
account for the transcriptional activation dependent on
TBL1 and/or TBLR1. Yoon et al. [35] were unable to find
any evidence for transcriptional activation in their studies,
which postulated a role for TBL1/TBLR1 in histone code
reading. Knock-down experiments using small interfer-
ence RNA (siRNA) techniques indicate that TBL1 and
TBLR1 are functionally redundant but essential for repres-
sion by unliganded thyroid hormone receptors [9]. Tom-
ita et al. used the frog oocyte system to demonstrate that
unliganded TBLR1 interacts with T3R and recruits TBLR1
to its chromatinized target promoter in vivo, accompanied
by histone deacetylation and gene repression and showed
that the recruitment of TBLR1 or related proteins is impor-
tant for repression by unliganded T3R [11]. Yoon et al.
have demonstrated that there is an additional site of inter-
action between a site near the most N-terminal of the WD-
40 repeats of TBL1 and the RD4 region of N-Cor [9]. These
interaction sites on SMRT flank the SANT motifs and it has
been suggested that they play a role in interpreting the his-
tone code and promoting histone deacetylation [36].
Expression of a TBLR1 fragment that contains this interac-
tion site, but lacks the C-terminal two-thirds of the mole-
cule including the WD-40 repeats, leads to a partial
proliferation arrest, suggesting again, the multiplicity of
roles that these family member play [18-21].
The proteins of the TBLR1 family also contain variant F-
box near the N terminus of the molecule. F-box proteins,
in combination with Skp1 and Cullin, form part of an E3
ubiquitin ligase that plays a critical role in the targeting of
phosphorylated proteins for ubiquitination and subse-
quent proteasomal degradation. Because proteolysis is
irreversible, proteasomal degradation provides a unidirec-
tional regulatory switch. The initiation of DNA replica-
tion, chromosome segregation, and exit from mitosis are
all triggered by the destruction of key regulatory proteins
[37] [38-39] The F-boxes in TBLR1, TBL1 and ebi all lack a
tryptophan near the NH2-end of the motif that is associ-
ated with Skp1 binding to F-box proteins that recognize
phosphorylated protein [40]. A cDNA, described only as
the "human homologue of ebi" encodes a protein that the
authors believe plays a role in the ubiquitin mediated
destruction of β-catenin [33] and they suggest that this ebi
can bind Skp1 and is a key component in a pathway that
targets unphosphorylated proteins for ubiquitination and
subsequent proteasomal degradation [33] [41].
Ectopic expression of full-length TBL1 potentiates repres-
sion by unliganded T3R. TBL1 does not bind directly to
T3R; it binds to SMRT and/or N-CoR and this interaction
was reported to contribute an autonomous repression
function to the complex. The methods used in these
experiments could not distinguish among the possibili-
ties; 1) that TBL1 changed the structure of N-CoR, perhaps
by altering the accessibility of the SANT motifs, producing
increased repression, 2) that it increased the quantity of
N-CoR present in the target cells or 3) that it facilitated the
recruitment of an additional co-repressor. We have shown
that over expression of TBLR1 or either the C- or N-termi-
nal truncates increases the expression of NHR co-repres-
sors. Co-transfection of TBLR1 with SMRT(1-300) leads to
greatly enhanced expression of a truncated SMRT in a
transient expression model and cells in which TBLR1 is
stably over expressed have elevated levels of endogenous
N-Cor. Co-transfection with the wild type TBLR1 as well
as both the N- and C-terminal truncates leads to a signifi-
cant increase in both SMRT(1-300) and endogenous N-
CoR expression. Thus, both ends of the molecule can
independently contribute to co-repressor stabilization.
Alternatively, the region between a.a. 80 and 175, and
shard in all of our constructs) may play an autonomous
role in increasing co-repressor expression. Since SMRT(1-
300) is degraded via a ubiquitin-mediated mechanism
and inhibition of ubiquitination leads to elevation of
SMRT, our data suggest the possibility that TBLR1 may act
by preventing the degradation of nuclear co-repressors.
This stabilization appears to be part of a complex regula-
tory network that governs the level of unliganded nuclear
receptor. Although this result is the opposite of what
might have been predicted on the basis of the results
described above for ebi-mediated targeting of β-cateninBMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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[33]both sets of data suggest that the TBLR1 family inter-
acts with proteins subject to proteasomal degradation and
the actual outcome, protection or targeting, may depend
on either the nature of the target protein or the identity of
the other proteins that interact with TBLR1. It may also be
controlled by which of the TBLR1 family members does
the interacting.
The mechanism through which the steady state level of
SMRT and N-CoR expression is regulated is not obvious.
The truncated construct of TBLR1 [TBLR1[δN] containing
the C-terminal half of the molecule lacks the sequence
involved in binding to the RD1 region of the co-repressors
but has the greatest effect on both SMRT and N-CoR
expression. Although this fragment contains most of the
sequence that Yoon et al. suggested is responsible for
binding the RD4 region of the co-repressor, the SMRT(1-
300) fragment that we used lacks this RD4 region. Thus
can not identify the binding partner responsible for the
increased co-repressor levels found in cells over-express-
ing TBLR1. It may be that oligimerization of TBLR1 is
required co-repressor stabilization and that a heteromeric
multimer of a truncated form with the wild type may form
a complex with SMRT that is an unsuitable substrate for
proteasomal degradation. Pulse-chase experiments with
co-transfected SMRT(1-300) suggest that ectopically
expressed TBLR1 [δN] stabilizes SMRT (data not shown)
but the pulse chase experiments do not provide an expla-
nation for the increased level of SMRT expression associ-
ated with co-transfection of either the N-terminal
fragment of TBLR1 or the whole molecule.
The fluorescence studies show that the intracellular distri-
bution of TBLR1 is influenced by the metabolic state of
the cells. The increase in nuclear staining may either rep-
resent translocation to the nucleus or nuclear trapping. In
either case, it is likely that the TBLR1 that accumulates in
the nucleus is degraded with different kinetics than the
cytoplasmic material and that differential localization as
well as alterations in proteasomal targeting, are the expla-
nation for the effect of increased TBLR1 expression on co-
repressor levels.
These results suggest that the TBL1-TBLR1 family plays a
role in the regulation of N-Cor and/or SMRT expression;
the amino terminal end docks the molecule to the co-
repressor, perhaps altering its intracellular localization
and targeting it for degradation. The carboxyl end appears
to contribute to this activity but also appears to be the
source of tissue specificity.
In summary, we have identified TBLR1 as a transcriptional
regulator interacting with the co-repressors of nuclear hor-
mone receptor activity. We have cloned the gene encoding
this protein and identified it as a member of a small fam-
ily of proteins that include at least two isoforms encoded
by the same gene and closely related, X- and Y linked pro-
teins, called TBL1X and TBL1Y. The evidence suggests that
these proteins act by altering the stability of the co-repres-
sor complex and that they may also contribute, or recruit
other proteins that provide, an autonomous repressor
function.
Methods
Cell culture, reagents and plasmids
COS7 cells are grown in Dulbecco's modified eagle
medium (DMEM) with 10% fetal bovine serum (FBS) at
37°C, 5% CO2. MG132 was purchased from Sigma
Chemical (St. Louis, MO.). PcDNA4.1His/Max and
PGEX6p-1 were purchased from Invitrogen and Pharma-
cia respectively. TBLR1 cDNA and a variety of truncated
derivatives were amplified from PcDNA.TBLR1 plasmid
using proof reading Taq polymerase. A truncated SMRT
cDNA SMRT(1-300) containing the first 900 nucleotides
of the message and encoding the amino terminal 300 a.a.
of the 2473 a.a. protein was amplified from a human pla-
centa cDNA library. This fragment contains the RD1
domain of SMRT but lacks RD2 and RD3. It also lacks the
C-terminal ID domains as well as both SANT domains
[36]. PCR products were cloned in frame into
PcDNA4.1His/Max for mammalian expression or in vitro
translation and cloned in frame into PGEX6p-1 plasmid
for bacterial expression.
Northern analysis
Multiple Tissue Northern Blot™ membranes were pur-
chased from Clontech. Hybridizations were performed
with [α32P]dATP labeled probes that also contained a
modified dCTP to facilitate removal of the hybridized
probe so that the blot can be hybridized repeatedly (Strip-
ez™, Ambion Inc, Austin TX 78744).
Real Time Quantitative PCR (rtqPCR)
A panel of total RNA from human tissues (First Choice
Human Total RNA) was purchased from Ambion, Inc.
Real-time RT-PCR was performed using a SYBR Green
PCR kit (SuperArray) and the iCycler Real-Time PCR
Detection System (BioRad). PCR was conducted at 95°C
for 5 min, followed by 40 cycles at 95°C for 60 seconds,
55°C for 30 seconds, and 72°C for 40 seconds. Data was
collected at 72°C, and a melting curve analysis was done
at the end of the cycling program to verify the quality of
PCR products. In some experiments the PCR products
were collected and electrophoresed through a 1.0% (W/V)
agarose gel to confirm the product size. Except for those
used to identify TBLR1β, the primers were purchased from
Super Arrays Inc and had the characteristics listed in Table
2. The primer pair used to identify TBLR1β had the
sequence: sense 3'-CTGCCTCACCATTTGGTTGT; 3'-
ATCTGCAAAACCGTTGGAAA.BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
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Preparation of cell lines ectopically expressing TBLR1
Jurkat cells were used to produce cells lines that stable
expressed TBLR1 and its variants TBLR1, TBLR1 [δN] and
TBLR1 [δC] constructs were made using proof reading
PCR. Each sequence was amplified from templates with
EcoR1 and Xho1 sites on the 5' and 3' ends. The amplified
products were digested and the fragments were cloned
into the MIG vector provided by Dr. David Baltimore. This
vector contains an IRES site downstream of the cloning
site and this is followed by a sequence encoding green flu-
orescent protein (GFP). Phoenix 293-Ampho cell line
were used to produce the viruses. They were cultured in
10% FCS DMEM to 80% confluence and transfected with
3  μg of each construct and 1 μg of VSVg using Lipo-
fectamine-2000 in the presence of 2 ug/ml of polybrene.
The medium was changed at 24 hours. 72 hours after the
transfection, the medium containing virus was collected
and used to infect the Jurkat cells. Five days after infection,
each Jurkat cell line was sorted for GFP positive cells. The
sorted green cells were maintained in 10% FCS RPMI
medium. The expression levels of the expressed proteins
were confirmed by Western blotting.
Anti TBLR1 antibodies
To facilitate analyzing the expression of the TBLR1 pro-
teins, the deduced peptide sequences were used to prepare
anti-peptide antibodies directed against the non-identical
portions of the two isoforms. Rabbits were immunized
with the carboxyl terminal peptides of TBLR1α and
TBLR1β. The deduced sequences of the C-terminal pep-
tides are:
TBLR1  α TQTGALVHSYRGTGGIFEVCWNA(C)AGDKV-
GASASDGSVCVLDLR
TBLR1  β TQVCLHYLNGQVLLNLGRSICLYTLPHHLVVI-
PLVALIELLVLK
The rabbits were immunized with the peptides shown in
bold face above coupled to ovalbumin in Freund's Adju-
vant (CFA) and boosted with the same antigens in Incom-
plete Adjuvant every 2 weeks for a total of 4 injections.
Antibody titers were measured by ELISA using both the
immunizing peptide and the recombinant TBLR1. Since
the peptide used to produce the antibody for TBLR1α is
identical to the homologous peptide found in TBL1, we
also prepared an antibody directed against the region of
TBLR1 (amino acids 117–125; AASQQGSAK) that dif-
fered most from TBL1. The resultant antibody was then
absorbed with a peptide (CGVSHQNPSK-amide coupled
to acrylamide) representing the equivalent sequence in
TBL1, to further reduce cross-reactivity. The resultant anti-
body was then affinity purified using the immunizing
peptide. The site recognized by this antibody is 30 amino
acids downstream of the putative F-box in the amino ter-
minal half of TBLR1.
Western blotting
1.0–2.0 mg of tissue or 10–20 million cells were lysed
with SDS-lysis buffer and the lysates denatured at 100°C
for 5 minutes. Samples were electrophoresed through
either 10% SDS gels, transferred to nitrocellulose mem-
branes, blocked with 5% non-fat milk and stained with
the primary antibody at the dilution recommended by the
distributor. The membrane was washed and stained with
a secondary, horseradish peroxidase-labeled conjugate.
After washing, the membranes were exposed to a detec-
tion cocktail containing hydrogen peroxide, phenol, and
luminol and the light emitted by the HRP/hydrogen per-
oxide catalyzed oxidation of luminol, was detected by
blue-light sensitive autoradiography film. In some experi-
ments the TBLR1 proteins were isolated by immuno-affin-
ity chromatography using the reagents provided by Pierce
Chemical in their Seize Primary Immunoprecipitation kit.
Rabbit anti-TBLR1(117-125) described above was cova-
lently coupled to the gel. The bound material was eluted
with a glycine-HCl buffer (pH 2.8) and then run on the
gels.
Immunofluorescence
Mouse 3T3 cells were grown in DMEM with 10% fetal
bovine serum. washed, fixed with 3.8% paraformalde-
hyde, permeabilized with 0.0.5% Triton-PBS and blocked
with 10% human serum in PBS. They were then incubated
with either anti-TBLR1 [117-125] or anti TBLR1β anti-
body (1:25) and stained with FITC-F(ab')2 anti-rabbit IgG
antibody that had previously been absorbed to render
them unreactive with human immunoglobulins (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA, USA
19390). Normal rabbit serum was used as a control.
Table 2: 
Gene Symbol RefSeq Accession # Reference positions Band Size (bp) Gene Symbol
TBL-1 TBL1X NM_005647.2 2185–2203 114
TBLR-1 IRA1 NM_024665.2 474–494 159
N-CoR NCOR1 NM_006311.2 7531–7549 149
SMRT NCOR2 NM_006312.1 6820–6840 83
GAPD GAPD NM_002046.2 162–183 108BMC Cell Biology 2006, 7:31 http://www.biomedcentral.com/1471-2121/7/31
Page 16 of 17
(page number not for citation purposes)
Cell cycle parameters
Cells in log phase growth were washed, resuspended in
PBS and fixed in PBS paraformaldehyde (0.25%final).
After 15 min at room temperature the cells were washed
once with PBS and the pellet suspended in cold methano
(-20°C)l. After 20 minuutes the cells were again washed
aresuspended in PBS containing RNAse (100 ug/ml) After
20 minutes at 37°C the samples were resuspended in pro-
pidiumiodide (PI) at 10 ug/ml. The cells were analyzed
after 90 minutes of staining.
Immunohistochemistry
Slide-mounted tissue sections are deparaffinized and
hydrated through graded alcohols to running water. All
slides are treated with 3°/v hydrogen peroxide in metha-
nol for 30 min to remove endogenous peroxidase activity.
All 3 antibodies were used at a final concentration of 1:25
and detected with HRP (horseradish peroxidase) coupled
goat anti rabbit IgG that had been absorbed to reduce
reactivity with human immunoglobulins (Jackson Immu-
noResearch Laboratories). Normal rabbit serum was used
as a control.
Co-immunoprecipitation
COS7 cells were transfected using lipofectamine (Gibco).
After 48 hours, the cells were collected and proteins
extracted with RIPA buffer. The protein extracts were incu-
bated with the primary monoclonal antibody for 4 hours
at 4°C and the resulting complexes bound to protein A/S
agarose beads. After washing with RIPA buffer, the beads
were resuspended in loading buffer and boiled for 5 min-
utes to elute the proteins. These proteins were used for
Western blotting.
Growth arrest after transfection
HK293T cells were stained with 50 uM of the lipophilic
carbocyanine, DiI (Molecular Probe cat# V-22885), in
serum free DMEM for 8 minutes at 37°. After 3 washing
with warm medium 200,000 cells were transferred to each
well of a 6 well cluster plate. The cells were transfected
with either an empty PCDNA4 control vector or PCDNA4
derived vectors containing TBLR1, TBLR1 [δN] or TBLR1
[δN] using Lipofectamine 2000 (Invitrogen). 4 μg of plas-
mid was used for each transfection. After 48 and, 72
hours, the cells from each well were harvested and ana-
lyzed for the expression DiI. The data was analyzed using
the "Proliferation Wizard" included in ModFit LT for
Win32 (Verity Software House, Topsham, ME 04086).
Sequence analysis
Plasmid DNA was sequenced by the chain termination
method in the Core Sequencing Facility of NYU Cancer
Institute using an Applied Biosystems automated
sequencer. The resulting sequences as well as the ESTs that
were identified using the NCBI BLAST program were
assembled using Sequencher software (Gene Codes Corp.,
Ann Arbor, MI) under a license to the Research Comput-
ing Resources of the NYU Medical Center.
GST pull-down experiment
35S labeled proteins were synthesized in vitro using a T7 in
vitro translation kit from Promega. GST and GST fusion
proteins were induced with 0.1 mM IPTG and purified on
glutathione-agarose column. To perform pull-down
experiments, 10 ul of 35S labeled proteins were mixed
with 20 ul 50% agarose coupled with GST or GST fusion
proteins in 150 ul PBS. The reaction was incubated with
frequent rotation for 2 hrs at 4°C, and then washed exten-
sively with PBS, containing 0.1% NP40. The beads were
resuspended in SDS-PAGE loading buffer, boiled for 5
minutes to elute the bound proteins which were electro-
phoresed on 10% SDS-PAGE gel and visualized with a
phosphorimager.
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